Company’s 36-month beta value is 1.85.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for PSNL is 43.93M, and currently, short sellers hold a 9.87% ratio of that floaft. The average trading volume of PSNL on April 11, 2025 was 1.07M shares.
PSNL) stock’s latest price update
Personalis Inc (NASDAQ: PSNL) has experienced a decline in its stock price by -10.36 compared to its previous closing price of 3.38. However, the company has seen a fall of -8.18% in its stock price over the last five trading days. businesswire.com reported 2025-03-26 that FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025. About Personalis, Inc. At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the.
PSNL’s Market Performance
Personalis Inc (PSNL) has seen a -8.18% fall in stock performance for the week, with a -20.68% decline in the past month and a -45.89% plunge in the past quarter. The volatility ratio for the week is 16.39%, and the volatility levels for the past 30 days are at 9.39% for PSNL. The simple moving average for the past 20 days is -12.82% for PSNL’s stock, with a -30.74% simple moving average for the past 200 days.
Analysts’ Opinion of PSNL
Many brokerage firms have already submitted their reports for PSNL stocks, with Craig Hallum repeating the rating for PSNL by listing it as a “Buy.” The predicted price for PSNL in the upcoming period, according to Craig Hallum is $8 based on the research report published on March 17, 2025 of the current year 2025.
Needham, on the other hand, stated in their research note that they expect to see PSNL reach a price target of $8. The rating they have provided for PSNL stocks is “Buy” according to the report published on February 06th, 2023.
PSNL Trading at -27.75% from the 50-Day Moving Average
After a stumble in the market that brought PSNL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.92% of loss for the given period.
Volatility was left at 9.39%, however, over the last 30 days, the volatility rate increased by 16.39%, as shares sank -15.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.52% lower at present.
During the last 5 trading sessions, PSNL fell by -8.18%, which changed the moving average for the period of 200-days by +146.34% in comparison to the 20-day moving average, which settled at $3.48. In addition, Personalis Inc saw -47.58% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PSNL starting from Tachibana Aaron, who sale 708 shares at the price of $5.79 back on Jan 28 ’25. After this action, Tachibana Aaron now owns 166,390 shares of Personalis Inc, valued at $4,099 using the latest closing price.
Chen Richard, the CHIEF MEDICAL OFFICER AND EVP of Personalis Inc, sale 519 shares at $5.79 during a trade that took place back on Jan 28 ’25, which means that Chen Richard is holding 123,367 shares at $3,005 based on the most recent closing price.
Stock Fundamentals for PSNL
Current profitability levels for the company are sitting at:
- -0.81 for the present operating margin
- 0.32 for the gross margin
The net margin for Personalis Inc stands at -0.96. The total capital return value is set at -0.29. Equity return is now at value -48.91, with -32.82 for asset returns.
Based on Personalis Inc (PSNL), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -1.02. The debt to equity ratio resting at 0.22. The interest coverage ratio of the stock is -2625.65.
Currently, EBITDA for the company is -70.3 million with net debt to EBITDA at 0.67. When we switch over and look at the enterprise to sales, we see a ratio of 2.6. The receivables turnover for the company is 10.39for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.46.
Conclusion
In a nutshell, Personalis Inc (PSNL) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
